quinta-feira, janeiro 06, 2005

Kivexa aprovado pela EMEA

Mais um comprimido "dois-em-um" no mercado europeu.

The Body 23.12.04

GSK Gains European Approval for Combination Antiretroviral Drug Kivexa

GlaxoSmithKline on Wednesday announced that it has received marketing approval from the European Commission for its antiretroviral drug Kivexa, which is a once-a-day tablet that combines the company's Epivir and Ziagen, known generically as lamivudine and abacavir, respectively, Reuters reports.

Comments: Enviar um comentário

<< Home

This page is powered by Blogger. Isn't yours?

Enter your email address below to subscribe to Blog do GAT!

powered by Bloglet